GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8F) » Definitions » PB Ratio

Biofrontera AG (XTER:B8F) PB Ratio : 1.57 (As of May. 13, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-13), Biofrontera AG's share price is €0.342. Biofrontera AG's Book Value per Share for the quarter that ended in Sep. 2023 was €0.22. Hence, Biofrontera AG's PB Ratio of today is 1.57.

The historical rank and industry rank for Biofrontera AG's PB Ratio or its related term are showing as below:

XTER:B8F' s PB Ratio Range Over the Past 10 Years
Min: 1.16   Med: 11.59   Max: 91.58
Current: 1.57

During the past 13 years, Biofrontera AG's highest PB Ratio was 91.58. The lowest was 1.16. And the median was 11.59.

XTER:B8F's PB Ratio is ranked better than
61.59% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2 vs XTER:B8F: 1.57

During the past 12 months, Biofrontera AG's average Book Value Per Share Growth Rate was -20.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 15.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 32.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Biofrontera AG was 89.30% per year. The lowest was -17.80% per year. And the median was 32.15% per year.

Back to Basics: PB Ratio


Biofrontera AG PB Ratio Historical Data

The historical data trend for Biofrontera AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG PB Ratio Chart

Biofrontera AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.68 20.70 19.73 1.46 4.78

Biofrontera AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.13 4.78 4.36 3.24 2.52

Competitive Comparison of Biofrontera AG's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofrontera AG's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biofrontera AG's PB Ratio falls into.



Biofrontera AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biofrontera AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2023)
=0.342/0.218
=1.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Biofrontera AG  (XTER:B8F) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biofrontera AG PB Ratio Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofrontera AG (XTER:B8F) Business Description

Traded in Other Exchanges
Address
Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377
Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8F) Headlines

No Headlines